Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 17Thoracic 6Lymphoid 6Genitourinary 6Gastrointestinal 6Breast 3Tumor-Agnostic 2Sarcoma 2Gynecologic 2Endocrine 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Head & Neck 1

Conditions

Sarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neurocytoma 1Gliosarcoma 1Glioblastoma 1Ganglioglioma 1Craniopharyngioma 1Astrocytoma 1

Interventions

Radiotherapy 221Cyclophosphamide 211Doxorubicin 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 81Irinotecan 79pembrolizumab 75Radiation 70Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Surgical Procedures, Operative 57Peripheral Blood Stem Cell Transplantation 57Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
antineoplaston A10 × Sarcoma × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003521 2017-09-29

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

Burzynski Research Institute

Phase 2 Terminated
14 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡